adenosine diphosphate has been researched along with losartan potassium in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (77.78) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adair, C; Cotes, PM; Lappin, TR | 1 |
| Gerber, G; Grune, T; Hampl, H; Riedel, E; Siems, W; Wendel, G | 1 |
| Azzadin, A; Bialkowska, A; Buczko, W; Chabielska, E; Mazerska, M; Mysliwiec, M; Pawlak, D | 1 |
| Dobos, G; Gawaz, MP; Gurland, HJ; Mujais, SK; Schollmeyer, P; Späth, M | 1 |
| Cierniewski, CS; Krzesłowska, J; Luciak, M; Rysz, J | 1 |
| Azzadin, A; Borawski, J; Buczko, W; Kalinowski, M; Malyszko, J; Malyszko, JS; Mysliwiec, M; Rydzewski, A | 1 |
| Kesselring, F; Porzig, H; Spicher, K | 1 |
| Akmal, M; el-Shahawy, MA; Francis, R; Massry, SG | 1 |
| Belch, JJ; Henderson, IS; Stewart, WK; Taylor, JE | 1 |
| Dudley, JM; Messinezy, M; Pearson, TC; Sawyer, B; Westwood, N | 1 |
| Adler, S; Bruns, FJ; Fraley, DS; Zeigler, ZR; Zirkman, DM | 1 |
| Malyszko, J; Malyszko, JS; Mysliwiec, M; Pawlak, K | 1 |
| Brause, M; Delabar, U; Eckardt, KU; Gleiter, CH; Zebski, H | 1 |
| Calls, J; Cases, A; Escolar, G; Ordinas, A; Reverter, JC; Tàssies, D | 1 |
| Eckle, T; Eltzschig, HK; Gleiter, CH; Grenz, A; Kloor, D; Köhle, C; Osswald, H; Schnermann, J; Vallon, V; von Wietersheim, S; Weingart, J; Zhang, H | 1 |
| Abel, K; Bjørn, SE; Bochsen, L; Gerwien, J; Johansson, PI; Kirkeby, A; Kjalke, M; Leist, M; Theilgaard-Monch, K; Torup, L | 1 |
| Antonilli, L; Brusadin, V; Catalano, M; Chece, G; Cipriani, R; Eusebi, F; Fredholm, BB; Lauro, C; Limatola, C; Trettel, F; van Rooijen, N | 1 |
| Aalto, K; Jalkanen, S; Liukkonen, J; Loukovaara, S; Sandholm, J; Yegutkin, GG | 1 |
2 trial(s) available for adenosine diphosphate and losartan potassium
| Article | Year |
|---|---|
A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.
Topics: Adenosine Diphosphate; Adult; Anemia; Arachidonic Acid; Biomarkers; Bleeding Time; Blood Platelets; Blood Proteins; Erythropoietin; Female; Fibrinolysis; Hematocrit; Hemoglobins; Hemostasis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation; Recombinant Proteins; Renal Dialysis; Ristocetin; Serotonin; Thromboembolism; Time Factors | 1995 |
Effect of recombinant human erythropoietin treatment on circulating reticulated platelets in uremic patients: association with early improvement in platelet function.
Topics: Adenosine Diphosphate; Adult; Age Factors; Aged; Blood Platelets; Erythropoietin; Female; Hematocrit; Humans; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation; Platelet Count; Recombinant Proteins; RNA; Time Factors; Uremia | 1998 |
16 other study(ies) available for adenosine diphosphate and losartan potassium
| Article | Year |
|---|---|
Changes in concentrations of ATP and other nucleotides in erythrocytes during erythropoietin treatment in haemodialysis patients.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Adult; Aged; Erythrocytes; Erythropoietin; Female; Guanosine Diphosphate; Humans; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Ribonucleotides; Time Factors | 1992 |
Changed purine nucleotide concentrations and enzyme activities in erythrocytes of haemodialysis patients undergoing erythropoietin therapy.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Adult; Aged; Aspartate Aminotransferases; Erythrocytes; Erythropoietin; Female; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Purine Nucleotides; Renal Dialysis | 1992 |
Serotonin is involved in some effects of erythropoietin.
Topics: Adenosine Diphosphate; Animals; Blood Pressure; Drug Interactions; Erythropoietin; Male; Platelet Aggregation; Rats; Rats, Inbred Strains; Recombinant Proteins; Serotonin | 1992 |
Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Antibodies, Monoclonal; Epitopes; Erythropoietin; Female; Fibrinogen; Flow Cytometry; Hemorrhagic Disorders; Humans; Kidney Failure, Chronic; Male; Molecular Sequence Data; Oligopeptides; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Binding; Protein Conformation; Recombinant Proteins; Renal Dialysis; Tetradecanoylphorbol Acetate | 1994 |
Expression of fibrinogen receptors and GPIIb molecules on uraemic platelets: effect of recombinant human erythropoietin therapy.
Topics: Adenosine Diphosphate; Adult; Bleeding Time; Blood Platelets; Erythropoietin; Female; Hematocrit; Hemoglobins; Humans; Injections, Subcutaneous; Integrin alpha2; Male; Membrane Glycoproteins; Middle Aged; Platelet Activation; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Renal Dialysis; Uremia | 1995 |
Changes in G protein pattern and in G protein-dependent signaling during erythropoietin- and dimethylsulfoxide-induced differentiation of murine erythroleukemia cells.
Topics: Adenosine Diphosphate; Adenosine Diphosphate Ribose; Animals; Cell Differentiation; Cell Division; Cyclic AMP; Dimethyl Sulfoxide; Drug Synergism; Erythroid Precursor Cells; Erythropoietin; Gene Expression Regulation, Leukemic; GTP-Binding Proteins; Humans; Isoproterenol; Leukemia, Erythroblastic, Acute; Mice; Neoplasm Proteins; Neoplastic Stem Cells; Pertussis Toxin; Receptors, Adrenergic, beta; Recombinant Proteins; Signal Transduction; Thrombin; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1994 |
Recombinant human erythropoietin shortens the bleeding time and corrects the abnormal platelet aggregation in hemodialysis patients.
Topics: Adenosine Diphosphate; Aged; Anemia; Bleeding Time; Collagen; Epinephrine; Erythropoietin; Female; Hematocrit; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Recombinant Proteins; Renal Dialysis; Thrombin | 1994 |
Erythropoietin does not increase whole-blood platelet aggregation in vitro.
Topics: Adenosine Diphosphate; Blood Platelets; Collagen; Erythropoietin; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Count; Renal Dialysis; Renal Insufficiency | 1994 |
Primary polycythaemia: diagnosis by non-conventional positive criteria.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Biomarkers; Blood Platelets; Cells, Cultured; Colony-Forming Units Assay; Diagnosis, Differential; Erythrocytes; Erythropoietin; Female; Humans; Interferon Type I; Interleukin-3; Ischemia; Male; Polycythemia; Polycythemia Vera; Recombinant Proteins; Reference Values; Thrombosis | 1993 |
Evaluation of platelet hyperfunction in hemodialysis patients receiving recombinant human erythropoietin.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Blood Platelet Disorders; Collagen; Erythropoietin; Female; Hematocrit; Humans; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation; Recombinant Proteins; Renal Dialysis; Ristocetin | 1993 |
Erythropoietin and uremic platelet aggregation in vivo and in vitro.
Topics: Adenosine Diphosphate; Adult; Aged; Anemia; Arachidonic Acid; Case-Control Studies; Collagen; Erythropoietin; Hemostasis; Humans; In Vitro Techniques; Middle Aged; Platelet Aggregation; Recombinant Proteins; Renal Dialysis; Ristocetin; Uremia | 1996 |
Evidence against a major role of adenosine in oxygen-dependent regulation of erythropoietin in rats.
Topics: Adenine; Adenosine; Adenosine Diphosphate; Animals; Antihypertensive Agents; Carbon Monoxide; Dipyridamole; Diuretics; Drug Synergism; Enzyme Inhibitors; Erythropoietin; Gene Expression; Hypoxia; Kidney; Male; Oxygen; Phenethylamines; Phosphodiesterase Inhibitors; Piperazines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; RNA, Messenger; Theophylline; Vasodilator Agents; Xanthines | 1997 |
Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxia.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Animals; Arteries; Carbon Monoxide; Erythropoietin; Extracellular Fluid; Hemodilution; Hypoxia; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; RNA, Messenger; Signal Transduction | 2007 |
High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).
Topics: Adenosine Diphosphate; Animals; Bleeding Time; Blood Proteins; Collagen; Dose-Response Relationship, Drug; Erythropoietin; Male; Mice; Neuroprotective Agents; P-Selectin; Platelet Activation; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Receptors, Proteinase-Activated; Recombinant Proteins | 2008 |
Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine Deaminase; Adenosine Diphosphate; Animals; Animals, Newborn; Brain-Derived Neurotrophic Factor; Cell Death; Cell Movement; Clodronic Acid; CX3C Chemokine Receptor 1; Erythropoietin; Glutamic Acid; Green Fluorescent Proteins; Hippocampus; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Neurons; Organ Culture Techniques; Rats; Receptor, Adenosine A1; Receptors, Adenosine A2; Receptors, Chemokine; Xanthines | 2010 |
Deregulation of ocular nucleotide homeostasis in patients with diabetic retinopathy.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adenylate Kinase; Adult; Aged; Chromatography, Thin Layer; Diabetic Retinopathy; Erythropoietin; Female; Humans; Male; Middle Aged; Nucleoside-Diphosphate Kinase; Retina; Statistics, Nonparametric; Vascular Endothelial Growth Factor A; Vitreous Body | 2017 |